US2003003564A1PendingUtilityA1

Methods and compositions for modulating ubiquitin dependent proteolysis

Assignee: MOUNT SINAI HOSPITAL CORPPriority: Oct 24, 1997Filed: Jan 29, 2002Published: Jan 2, 2003
Est. expiryOct 24, 2017(expired)· nominal 20-yr term from priority
C07K 14/4738A61K 38/00C07K 14/395
44
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to methods and compositions for modulating ubiquitin dependent proteolysis.

Claims

exact text as granted — not AI-modified
We claim:  
     
         1 . A method for modulating ubiquitin dependent proteolysis comprising administering an effective amount of one or more of the following: (a) a complex comprising an E2 ubiquitin conjugating enzyme, a protein of the Cullin family, and a F-box binding protein, and optionally a protein containing an F-box motif; (b) a complex comprising a protein of the Cullin family and a protein containing an F-box motif; (c) a peptide derived from the binding domain of an E2 ubiquitin conjugating enzyme that interacts with a protein of the Cullin family; (d) a peptide derived from the binding domain of a protein of the Cullin family that interacts with an E2 ubiquitin conjugating enzyme; (d) a peptide derived from the binding domain of a protein of the Cullin family that interacts with an F-box binding protein; (e) a peptide derived from the binding domain of an F-box binding protein that interacts with a protein of the Cullin family; (f) enhancers or inhibitors of the interaction of an E2 ubiquitin conjugating enzyme or a F-box binding protein, and a protein of the Cullin family.

Join the waitlist — get patent alerts

Track US2003003564A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.